Department of Biochemistry, University of Kashmir, Hazratbal, Srinagar, 190006, India.
Department of Basic Medical Sciences, College of Medicine, University of Bisha Kingdom of Saudi Arabia, Saudi Arabia.
Int J Biochem Cell Biol. 2019 Oct;115:105589. doi: 10.1016/j.biocel.2019.105589. Epub 2019 Aug 20.
TNF receptor proteins were primarily recognized as adaptor proteins that ligate with the tumor necrosis factor receptor (TNFR)-associated factor (TNFR) family to execute various signaling pathways. However, recent studies showed that they act as a signal-transducing molecules and are reported to have a functional role as a Toll/interleukin-1 receptor family member. Seven members of this family have been identified to date. Among TNF receptor family, TRAF7 does not share a common TRAF domain homology. The tumor necrosis factor receptor associated factor (TRAF) domain comprises of about 230 amino acid motif at the C-terminal region that has the capability to bind TNFR and execute different downstream signaling pathways. Moreover, N-terminal RING and ZINC finger constituted by the tumor necrosis factor associated protein 2 and tumor necrosis factor associated protein 6 are critical and execute various downstream signaling events. TRAF proteins have emerged as critical regulators that provide the cellular response to stress and lead to cell death. Nuclear factor kappa beta (NF-KB) and c-Jun N-terminal kinases (JNK) pathways are activated through tumor necrosis factor associated protein 2, tumor necrosis factor associated protein 5 and tumor necrosis factor associated protein 6 members. TRAF proteins in pathogenesis were observed from their abnormal expression in diseased tissue and in normal tissue, suggesting its important role in physiological processes. Recently, unique specificity of TRAF4 for glycoprotein Ibβ (GPIbβ) and glycoprotein VI (GPVI) in human platelets has been reported. The multifunctional effects of TRAIP (TNF) interacting protein in many cellular signaling pathways emerged as very important signaling molecule. Furthermore, the new insights into the structure of TRAF members along with new studies involved in health and disease prompted to explore their role particularly the TNF receptor associated proteins with novel inhibitor protein TRAIP (TNF) interacting protein and human diseases associated with it. As such, this review emphasis on tumor necrosis factor receptor associated proteins, present their current understanding with novel inhibitor protein TRAIP (TNF) interacting protein.
肿瘤坏死因子受体蛋白最初被认为是衔接蛋白,可与肿瘤坏死因子受体(TNFR)相关因子(TNFR)家族连接,执行各种信号通路。然而,最近的研究表明,它们作为信号转导分子发挥作用,并被报道具有作为 Toll/白细胞介素-1 受体家族成员的功能作用。迄今为止,已经鉴定出该家族的 7 个成员。在 TNF 受体家族中,TRAF7 不具有共同的 TRAF 结构域同源性。肿瘤坏死因子受体相关因子(TRAF)结构域包含约 230 个氨基酸基序,位于 C 末端区域,具有与 TNFR 结合并执行不同下游信号通路的能力。此外,由肿瘤坏死因子相关蛋白 2 和肿瘤坏死因子相关蛋白 6 构成的 N 端 RING 和 ZINC 指构成了关键的 TRAF 蛋白,执行各种下游信号事件。TRAF 蛋白已成为关键的调节剂,为细胞对压力的反应提供了保障,并导致细胞死亡。核因子 kappa beta(NF-KB)和 c-Jun N-末端激酶(JNK)途径通过肿瘤坏死因子相关蛋白 2、肿瘤坏死因子相关蛋白 5 和肿瘤坏死因子相关蛋白 6 成员激活。在疾病组织和正常组织中观察到 TRAF 蛋白的异常表达,表明其在生理过程中具有重要作用。最近,有人报道 TRAF4 对人血小板糖蛋白 Ibβ(GPIbβ)和糖蛋白 VI(GPVI)具有独特的特异性。TRAFIP(TNF)相互作用蛋白在许多细胞信号通路中的多功能作用已成为非常重要的信号分子。此外,随着新的研究涉及健康和疾病,对 TRAF 成员的结构的新见解促使人们探索其作用,特别是与 TNF 受体相关的蛋白质与新型抑制剂蛋白 TRAFIP(TNF)相互作用蛋白和与人类疾病相关的蛋白质。因此,本综述重点介绍肿瘤坏死因子受体相关蛋白,介绍它们目前对新型抑制剂蛋白 TRAFIP(TNF)相互作用蛋白的理解。